Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth.
about
Exploiting tumor epigenetics to improve oncolytic virotherapyAn envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptorEngineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinomaFusoselect: cell-cell fusion activity engineered by directed evolution of a retroviral glycoprotein.In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines.Combined administration with DNA encoding vesicular stomatitis virus G protein enhances DNA vaccine potencySequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope.Active adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytia.A Double-Switch Cell Fusion-Inducible Transgene Expression System for Neural Stem Cell-Based Antiglioma Gene Therapy.Mechanisms of Oncolysis by Paramyxovirus SendaiCombination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancerEpisodic Diversifying Selection Shaped the Genomes of Gibbon Ape Leukemia Virus and Related Gammaretroviruses.Oncolysis by paramyxoviruses: preclinical and clinical studies.Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.Oncolytic viruses in the treatment of bladder cancerSystemic delivery of fusogenic membrane glycoprotein-expressing neural stem cells to selectively kill tumor cells.Immune-mediated anti-neoplastic effect of intratumoral RSV envelope glycoprotein expression is related to apoptotic death of tumor cells but not to the size of syncytiaTumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.Measles virus induces persistent infection by autoregulation of viral replicationAdenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents.Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.Oncolytic viruses: do they have a role in anti-cancer therapy?Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigenA hyperfusogenic F protein enhances the oncolytic potency of a paramyxovirus simian virus 5 P/V mutant without compromising sensitivity to type I interferon.Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replication.Enhanced cytotoxicity without internuclear spread of adenovirus upon cell fusion by measles virus glycoproteins.Antitumor immunity can be uncoupled from autoimmunity following heat shock protein 70-mediated inflammatory killing of normal pancreasFusogenic Viruses in Oncolytic ImmunotherapyHuman Endogenous Retroviral Envelope Protein Syncytin-1 and Inflammatory Abnormalities in Neuropsychological Diseases
P2860
Q21131237-94A9EDEF-6EC0-407A-8924-266861D398FBQ24524784-918DC663-611D-42B3-9AB9-815715F71200Q24628144-BE49BB53-F5A7-412F-B749-E1BD5B140A80Q25256213-64FDBF94-FA3B-4D98-942D-C7D3B7560D4CQ30832171-87926C4F-E284-40BD-B6DA-7B44FA725975Q33649019-DC586F0D-25E5-4F9C-A50B-9C6EFDC95E7BQ34090039-5F64C63D-2150-412E-BDD3-029148DC58D8Q34473301-49B073E8-780E-4948-9976-795C046407C5Q35620945-78420412-3A2B-416C-8EB0-29223B975292Q35721486-2EE06418-35BC-4357-A72C-E083B25CA4C1Q35739482-E03AB6CD-88D0-4D43-87C5-6E92FA0B6629Q35861403-A52E5C87-FA3F-40FC-BCBE-C550C7B14BB3Q35861933-93132E0D-E380-4E71-B736-C54AEB29BF4FQ35861936-0D726356-DE27-412F-9BB1-B31C6B48481BQ36147934-3FBBB083-73FE-4F3E-A126-10403FFDF744Q37073094-2EF090F1-D53B-428B-AA20-5560A6187BCBQ37240366-240664A8-DC9B-4020-A33A-D8396B1DF4F0Q37336713-22A7EF69-336C-4D52-9FB5-C905EEEB20E6Q37435209-24E879DF-5F07-4DE5-A1F5-98E17F3FEBD8Q37628219-0B81E75F-BB7B-4F8B-AE22-0351D2D89510Q37629088-A86C7B97-BF32-4493-848B-6EBAE84D6394Q37926486-3EFD8A60-FE05-4AAC-ABB4-E454467FCF0EQ39605575-37DE1AF3-EAD2-49DF-93C8-11E9F03ADD6BQ39955752-F7E36B7F-5865-450F-A466-B9BFDFA310E7Q39977445-AD8B0644-03D2-4BA6-9B31-5D9B38A505CFQ40471271-F641A494-1260-4528-88B2-5ABFB32D489AQ41878744-1323FDE9-DB5F-4812-822B-263D16C9A333Q56971929-8B0BFDFA-B173-4079-BDE5-32BAF1769A18Q58758788-0ED49987-61D4-44C3-9622-072D79573E9F
P2860
Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Fusogenic membrane glycoprotei ...... iated control of tumor growth.
@en
type
label
Fusogenic membrane glycoprotei ...... iated control of tumor growth.
@en
prefLabel
Fusogenic membrane glycoprotei ...... iated control of tumor growth.
@en
P2093
P1433
P1476
Fusogenic membrane glycoprotei ...... iated control of tumor growth.
@en
P2093
Bullough F
Cattaneo R
Emiliusen L
Russell SJ
P304
P407
P577
2000-03-01T00:00:00Z